Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genetics and Screening in Prostate Cancer.

The Surgical clinics of North America·2026

Same author

Nicotinamide for Skin Cancer Chemoprevention.

JAMA dermatology·2025

Same author

Identifying Borderline Trachoma Grades Using a Three-Latent Class Model.

The American journal of tropical medicine and hygiene·2025

Same author

NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024.

Journal of the National Comprehensive Cancer Network : JNCCN·2024

Same author

Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN·2024

Same author

Cellularity of mucus is a prognostic variable in low-grade appendiceal mucinous neoplasms.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2024

Search research articles

Related Experiment Video

Updated: Jul 31, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Prostate sarcoma.

Nicholas T Ehat¹, Lisa Chuong², Jenna Dickman²

¹Florida Atlantic University Charles E. Schmidt College of Medicine Boca Raton Florida USA.

IJU Case Reports

|May 5, 2023

Summary

This summary is machine-generated.

Prostatic sarcomas are rare cancers. This case highlights a high-grade sarcoma in a 72-year-old man, emphasizing radical prostatectomy as the primary treatment and staging as a key prognostic factor.

Keywords:

malignancy prostate prostatectomy sarcoma

More Related Videos

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Related Experiment Videos

Last Updated: Jul 31, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Area of Science:

Oncology
Urology

Background:

Prostatic sarcomas are rare and aggressive malignancies.
Literature review comparing demographics, histology, prognosis, and treatment strategies.

Observation:

A 72-year-old male presented with symptomatic nephrolithiasis.
MRI revealed an enlarged, heterogeneous prostate with a left lobe mass.
Biopsy confirmed high-grade undifferentiated sarcoma and concomitant adenocarcinoma.

Findings:

Radical prostatectomy is the most effective treatment for prostatic sarcoma.
Staging is the most critical prognostic indicator.
Variable presenting symptoms contribute to diagnostic challenges.

Implications:

Early diagnosis and appropriate staging are crucial for improving patient outcomes.
Further research into optimal treatment strategies for prostatic sarcomas is warranted.
Understanding the diverse presentations of prostatic sarcoma is essential for clinicians.